I now have comprehensive, textbook-sourced content with real MRI images. Let me compile the full radiology-focused guide on phakomatoses.
Phakomatoses - Radiology Resident Guide
Phakomatoses (neurocutaneous syndromes) are congenital disorders affecting structures of ectodermal origin - the nervous system, skin, and eye. They result in hamartomas and tumours in multiple organs. The five most commonly tested in radiology are: NF-1, NF-2, Tuberous Sclerosis, von Hippel-Lindau disease, and Sturge-Weber syndrome.
1. Neurofibromatosis Type 1 (NF-1)
Genetics: Autosomal dominant. Chromosome 17q11.2 - encodes neurofibromin (tumour suppressor). Most common inherited tumour syndrome; incidence 1:3,000-4,000. 50% are new mutations.
Diagnostic Criteria (≥2 required):
| Major Criteria | Radiological? |
|---|
| ≥6 café-au-lait spots (>5 mm prepubertal, >15 mm postpubertal) | No |
| Axillary/inguinal freckling (Crowe sign) | No |
| ≥2 neurofibromas OR ≥1 plexiform neurofibroma | Yes |
| Optic pathway glioma | Yes |
| ≥2 Lisch nodules (iris hamartomas) | No |
| Sphenoid dysplasia / long bone cortical thinning ± pseudoarthrosis | Yes |
| First-degree relative with NF-1 | No |
CNS Imaging Findings
"Unidentified Bright Objects" (UBOs) / Neurofibromatosis Bright Objects (NBOs):
- Present in 60-80% of NF-1 children; up to 95% with coexistent OPG
- T2/FLAIR hyperintense foci, no mass effect, no enhancement
- Typical sites: pons, cerebellar white matter, internal capsules, basal ganglia (may be slightly T1 hyperintense here), thalami, hippocampi
- Age-dependent: rare <4 years, peak 4-10 years, virtually absent after age 20
- Key distinction from glioma: no growth, no enhancement; enhancement or increasing mass effect should raise concern for tumour transformation
Fig. 76.27 - NF-1. (A) T2 axial: hyperintense UBOs in lentiform nuclei. (B) Coronal: UBOs in brainstem and midbrain. (C) T2 axial: bilateral optic nerve gliomas extending into the chiasm (arrows). - Grainger & Allison's
Optic Pathway Gliomas (OPGs):
- Most common brain abnormality in NF-1 (up to 15%); usually WHO grade I pilocytic astrocytoma
- NF-1 OPGs more often affect optic nerves (vs. chiasm/postchiasmatic in sporadic cases); better prognosis
- Fusiform optic nerve expansion; widening of optic foramen on CT
- MRI preferred: fat-suppressed T1+Gd and STIR sequences; 3 mm slices
- Once chiasm/hypothalamus involved: risk of precocious puberty and visual loss
Plexiform Neurofibromas:
- Major diagnostic criterion; multinodular, involve multiple nerve fascicles
- Classic site: orbit along ophthalmic V1, associated with sphenoid wing dysplasia
- CT: hypodense, minimal enhancement
- MRI: T1 low SI, T2 heterogeneous hyperintense; variable Gd enhancement; "target sign" (central T2 hypointensity) in neurofibromas
- Extension into pterygomaxillary fissure, orbital apex, cavernous sinus
- Malignant transformation to fibrosarcoma: 2-12%
Sphenoid Wing Dysplasia:
- Produces the "bare/empty orbit" sign on plain radiograph
- Temporal lobe herniation through the orbit
- Pulsatile exophthalmos (CSF pulsations transmitted through defect)
Other NF-1 CNS tumours: Brainstem gliomas (medulla/midbrain > pons - unusual for NF-1), cerebellar pilocytic astrocytomas (1-3%), tectal gliomas (can cause aqueductal stenosis + hydrocephalus)
Skeletal: Kyphoscoliosis (high thoracic acute curve), tibial bowing/pseudoarthrosis, lambdoid sutural dysplasia, rib notching (dumbbell neurofibromas), focal gigantism
2. Neurofibromatosis Type 2 (NF-2)
Genetics: Autosomal dominant. Chromosome 22q12 - encodes merlin/schwannomin. Incidence 1:50,000.
Diagnostic Criteria:
- Bilateral vestibular schwannomas (pathognomonic) - shown on MRI/CT or histology
- OR first-degree relative with NF-2 + unilateral 8th nerve tumour
- OR first-degree relative with NF-2 + any two of: neurofibroma, meningioma, schwannoma, glioma, or juvenile posterior subcapsular lens opacity
Key Imaging Features:
- Bilateral vestibular (acoustic) schwannomas - enhancing masses at the internal auditory canals (IAC); adults present with hearing loss; children more often with seizures or facial palsy
- Multiple meningiomas (often en plaque)
- Cranial nerve schwannomas (CN V, VII common)
- Ependymomas (especially spinal; cervical cord)
- Spinal schwannomas on cauda equina roots - dumbbell morphology, foraminal widening
- MRI protocol: Contrast-enhanced T1 with thin cuts through posterior fossa; FIESTA/CISS sequences for IAC; full spine survey
3. Tuberous Sclerosis Complex (TSC)
Genetics: Autosomal dominant (66-86% spontaneous mutations). Two genes:
- TSC1 - chromosome 9q34.3 - hamartin
- TSC2 - chromosome 16p13.3 - tuberin (adjacent to PKD1; more severe phenotype, more SEN nodules, renal angiomyolipomas)
- Both products form a functional unit regulating the mTOR pathway
Prevalence: 1:6,000
CNS Imaging Findings
Cortical Tubers:
- Hamartomatous cortical dysplasias; hallmark lesion; cause epilepsy
- CT: often calcified (higher density); may be occult early
- MRI: T2/FLAIR hyperintense; involves cortex + subcortical white matter; signal may invert (become T1 bright) as child matures
Subependymal Nodules (SENs):
- Project into ventricles along the caudate eminences ("candle drippings" appearance)
- Calcify with age → T2 hypointense on MRI (hyperdense on CT)
- Stable, non-enhancing; typically benign
Subependymal Giant Cell Astrocytomas (SEGAs):
- Most important complication: arise from SENs at/near the foramen of Monro
- Enhancing mass; causes obstructive hydrocephalus
- WHO grade I tumour; surgical or mTOR inhibitor (everolimus) treatment
- MRI: T1/T2 heterogeneous, avid Gd enhancement; size >1 cm and growth are key criteria
Fig. 76.29 - Tuberous Sclerosis. (A) T2 axial: multiple cortical/subcortical tubers; bilateral lesions at foramina of Monro consistent with giant cell astrocytomas (arrows). (B) T2 axial: subependymal nodules projecting into ventricles; markedly hypointense calcified nodule (arrowhead). - Grainger & Allison's
Radial Migration Lines (White Matter Lesions):
- T2 hyperintense lines extending from ventricle to cortex
- Reflect abnormal neuronal migration; not visible on CT
Systemic Imaging Findings
| Organ | Finding |
|---|
| Kidney | Angiomyolipomas (bilateral, multiple; fat-containing - T1 bright, loss of signal on fat-sat; CT: fat attenuation), renal cysts, renal cell carcinoma |
| Lung | Pulmonary LAM (lymphangioleiomyomatosis) - thin-walled cysts, predominantly in women; chylous effusion |
| Heart | Cardiac rhabdomyomas - echogenic masses; most regress spontaneously; can cause arrhythmia |
| Skeleton | Sclerotic bone islands (vertebral bodies, pedicles); irregular periosteal reaction (metacarpals); cyst-like phalangeal lesions |
| Eye | Retinal astrocytic hamartomas ("mulberry lesion") |
4. Von Hippel-Lindau (VHL) Disease
Genetics: Autosomal dominant. Chromosome 3p25 - VHL tumour suppressor gene (regulates HIF/VEGF pathway). Prevalence ~1:40,000.
Classification:
- Type 1 (no phaeochromocytoma): haemangioblastomas + renal/pancreatic lesions
- Type 2 (with phaeochromocytoma): subdivided by presence of RCC
Imaging Findings
CNS Haemangioblastomas (most important):
- Benign, slow-growing vascular tumours
- Sites: cerebellum (~50%, hemispheres >> vermis), spinal cord (intramedullary), medulla (area postrema)
- Classic MRI appearance: cyst with enhancing mural nodule (nodule is avid, cyst wall does not enhance)
- Solid variants occur (more common in brainstem)
- Spinal haemangioblastomas → syringomyelia (common)
- Screening: contrast-enhanced MRI brain + spine (pre + post T1 with thin posterior fossa cuts)
Fig. 99.17 - VHL: Multiple bilateral enhancing cerebellar haemangioblastomas. - Bradley & Daroff's
Retinal Angiomas: Reddish masses with feeding artery and draining vein; treated with photocoagulation
Renal Cell Carcinoma: Clear cell type; bilateral, multifocal; hypervascular on CT/MRI
Phaeochromocytoma: Bilateral in ~40%; T2 hyperintense "lightbulb" on MRI; avid enhancement; catecholamine excess
Pancreatic lesions: Simple cysts (most common), serous cystadenomas, pancreatic NETs (hypervascular)
Endolymphatic sac tumours (ELSTs): 10-15% of VHL; petrous bone; papillary appearance; T1 hyperintense areas (haemorrhage); cause hearing loss and tinnitus
5. Sturge-Weber Syndrome
Genetics: Sporadic; somatic activating mutation in GNAQ (disrupts G-protein alpha subunit GTPase activity). NOT inherited.
Classic Triad:
- Port-wine naevus (facial capillary haemangioma - forehead/upper eyelid distribution; V1 territory)
- Ipsilateral leptomeningeal angioma (parieto-occipital predominance)
- Glaucoma (ipsilateral; two age peaks: infancy and late childhood)
Only 10-20% of children with a port-wine naevus develop an intracranial angioma.
Imaging Findings
CT:
- "Tramline calcifications" - gyriform cortical calcifications (visible by ~2 years)
- Leptomeningeal angioma may not be visible without contrast in early life
- Ipsilateral hemispheric atrophy in established disease
MRI:
- Diffuse pial enhancement over affected hemisphere (variable thickness) - most sensitive finding
- Underlying cortical atrophy; T2 hypointensity within gyri (calcification)
- Ipsilateral choroid plexus enlargement - characteristic, due to collateral venous drainage
- Dilated transparenchymal medullary veins (T2 hypointense flow voids) communicating superficial-deep venous systems
- Bilateral involvement in ≥15% of patients (including some with unilateral nevus)
- "Burnt-out" cases: pial angioma may no longer enhance; shrunken calcified hemisphere remains
- Polymicrogyria may coexist
Fig. 76.30 - Sturge-Weber in a child with port-wine stain. (A) Coronal T1 post-contrast: enhancing pial angioma over atrophic right hemisphere; enlarged right choroid plexus; gyral calcification as T1 hypointense foci. (B) T2 axial: prominent superficial and ependymal veins (arrows). (C) Axial post-contrast T1: bilateral choroidal angiomas (arrows) plus pial angioma. - Grainger & Allison's
Quick-Reference Comparison Table
| Feature | NF-1 | NF-2 | TSC | VHL | Sturge-Weber |
|---|
| Gene/Chr | NF1 / 17q | NF2 / 22q | TSC1(9q), TSC2(16p) | VHL / 3p | GNAQ (somatic) |
| Inheritance | AD | AD | AD | AD | Sporadic |
| Pathognomonic CNS lesion | UBOs + OPG | Bilateral vestibular schwannomas | Cortical tubers + SEGAs | Cerebellar haemangioblastoma | Pial angioma |
| Key CT finding | Sphenoid dysplasia, "bare orbit" | CPA mass bilateral | Calcified SEN, tubers | - | Tramline calcifications |
| Key MRI finding | T2 UBOs (basal ganglia, pons); fusiform optic nerve | Bilateral IAC enhancing masses | Tubers, SEN, SEGAs at foramen of Monro | Cyst + enhancing mural nodule (cerebellum) | Pial enhancement, enlarged choroid plexus |
| Malignant risk | Fibrosarcoma (NF → 2-12%); MPNST | Low | RCC (TSC2), SEGA (benign) | RCC (clear cell), phaeo | Low |
| Skin | Café-au-lait, neurofibromas | Few | Ash-leaf spots, adenoma sebaceum, shagreen patch | - | Port-wine naevus (V1) |
| Eye | Lisch nodules | Posterior subcapsular cataract | Retinal astrocytic hamartoma | Retinal angioma | Glaucoma, choroidal angioma |
| Kidney | - | - | AML (fat-containing), cysts | RCC (bilateral, multifocal), cysts | - |
| Spine | Dumbbell neurofibromas, scoliosis | Ependymomas, schwannomas | - | Haemangioblastomas + syrinx | - |
Additional / Less Common Phakomatoses
Neurocutaneous Melanosis:
- Giant congenital melanocytic naevi (skin) + intracranial melanosis
- MRI: T1 shortening (melanin) in anterior/mesial temporal lobe, cerebellum, pons
- CT: areas of increased density (less conspicuous)
- Hydrocephalus from leptomeningeal involvement; rare malignant transformation
Wyburn-Mason Syndrome:
- Racemose (arteriovenous) malformations in retina
- Ipsilateral intracranial AVM (mid-brain/optic pathway); no treatment required unless symptomatic
PHACES Syndrome:
- Posterior fossa malformations (Dandy-Walker), facial Haemangiomas, Arterial anomalies, Cardiac/eye anomalies, Sternal cleft
Basal Cell Naevus Syndrome (Gorlin Syndrome):
- Multiple basal cell carcinomas, odontogenic keratocysts
- Calcification of falx cerebri (pathognomonic on CT/skull XR)
- Medulloblastoma (desmoplastic type); bifrontal cortical dysplasia
Key Radiology Pearls
- NF-1 UBOs: T2 bright, no enhancement, no mass effect → watch for change; if they enhance = suspect glioma
- NF-1 "bare orbit": Sphenoid wing dysplasia on plain film/CT
- TSC SEGAs: Grow at the foramen of Monro → obstructive hydrocephalus; any SEN >1 cm + enhancing = SEGA
- TSC AML: Fat attenuation on CT (<-10 HU); spontaneous retroperitoneal haemorrhage ("Wunderlich syndrome") if >4 cm
- VHL haemangioblastoma: Cyst + mural nodule in cerebellum of young adult → first think VHL (especially if multiple or spinal)
- Sturge-Weber: Early MRI may be normal - pial enhancement is the earliest MRI sign, calcifications come later; enlarged ipsilateral choroid plexus is characteristic
- NF-2: Any bilateral IAC masses = NF-2 until proven otherwise
Sources: Grainger & Allison's Diagnostic Radiology (Table 76.2, Figs. 76.27-76.32); Bradley & Daroff's Neurology in Clinical Practice (Boxes 99.1-99.2, Chapter 99)